At the University of São Paulo, researchers have done what medicine could not do for this condition just a decade ago: they have named the molecular culprit behind a rare childhood neurological disease, tracing its devastation to a single malfunctioning protein. CONDSIAS — a disorder that strips children of coordination, invites seizures, and worsens with every common viral illness — has now yielded its genetic secret, a novel variant in the ADPRS gene identified through the careful sequencing of an 11-year-old girl's DNA. In the long human effort to transform suffering from mystery into meani
CNN Brasil
· May 26, 2026
· health
· 1 min read
High
Sourcing: Verified
USP researchers identify genetic variant explaining rare childhood neurological disease
An 11-year-old girl with CONDSIAS experiences progressive neurological deterioration including epilepsy, motor coordination loss, and developmental delays, with symptoms severely worsened by viral infections.
◉
Health & Medicine
2697 related articles
Ozempic and GLP-1 drugs: how the weight-loss revolution works and what…
O GLOBO · 99% match
Eli Lilly's retatrutida shows 28% weight loss in trials, rivaling bari…
Poder360 · 90% match
GLP-1 drugs like Ozempic expand beyond weight loss into Alzheimer's, h…
Folha de S.Paulo · 90% match
Brazil's obesity guidelines shift focus from weight loss to disease ma…
Correio Braziliense · 90% match
Medical Expert Warns of Tirzepatide Risks, Emphasizes Need for Profess…
UNIPAR · 90% match
Related Coverage
Folha de S.Paulo · Aug 18
Cisne mantém reinado como melhor sal entre paulistanos pela quinta vez
A marca Cisne vence pela quinta vez consecutiva a pesquisa Datafolha como melhor sal entre paulistanos, com 50% das menç…
Folha de S.Paulo · Aug 18 Projeto Quebrada Alimentada é eleito iniciativa de destaque em gastronomia pela FolhaO projeto Quebrada Alimentada, nascido no restaurante Mocotó durante a pandemia, foi eleito iniciativa de destaque pela …
UOL · Aug 17 Lucy Ramos revela que Globo consultou obstetra para cena de acidente na novelaA atriz Lucy Ramos revelou que a Globo consultou seu obstetra antes de gravar uma cena de acidente fatal enquanto ela es…
Estadão · Aug 17 Asma não impede atividade física; exercício regular ajuda no controle da doençaPesquisas confirmam que atividade física beneficia asmáticos, mas requer controle da doença e atenção a fatores ambienta…
Bias & Framing
⚖
Straightforward science reporting on USP genetic discovery with minimal bias; presents research findings factually with appropriate expert attribution and institutional context.
Bias Direction
center
Confidence
HIGH
Standard science journalism framing: discovery-focused narrative emphasizing institutional prestige (USP, Fapesp), expert credibility through direct quotes, and clinical significance of findings. Frames research as advancing diagnostic capability and potential therapeutic understanding.
Patient/family perspective on living with CONDSIAS
Broader context on rare disease research funding and accessibility
Timeline or next steps for therapeutic development
Comparison to similar genetic discoveries or international research efforts
Perspective from other research institutions or international collaborators
Geopolitical Impact
🌎
Brazilian researchers identify genetic variant for rare childhood neurological disease; primarily a scientific advancement with limited geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Brazil
South America
Demonstrates Brazil's scientific research capacity in genomics; strengthens regional medical knowledge leadership through USP and FAPESP collaboration.
Economic Lens
📈
USP researchers identified a novel genetic variant in ADPRS gene explaining CONDSIAS, a rare childhood neurological disorder. This discovery has limited direct economic impact but signals growth in genetic research and personalized medicine sectors.
Market Signal
neutral
Confidence
MED
Biotechnology and genetic research
Pharmaceutical development
Healthcare and diagnostics
Medical education and research institutions
Gene therapy development
Minimal immediate consumer impact as CONDSIAS is extremely rare (one documented case in South America). Long-term benefit: improved diagnostic accuracy for affected families and potential future therapeutic options. Increased awareness of genetic testing value may drive demand for genetic screening services.
Potential support for rare disease research funding and genetic sequencing infrastructure. May influence healthcare policies regarding coverage of genetic testing for neurological disorders. Could strengthen intellectual property frameworks for genetic discoveries in Brazil. May encourage international collaboration on rare disease research.